Dutch: Funding, Investors & Team (Sep 2026)

Dutch is a veterinary telehealth service that specializes in treating anxiety and allergies in pets. At Dutch, we’re on a mission to treat the curable ailments that keep our pets from living their best lives. Many of our pets suffer from chronic conditions such as allergies and anxiety. Sadly, many also go untreated. Traditional vet appointments are inconvenient, expensive, and often stressful for our best friends. This leads to putting off wellness visits until a pain point is unignorable and frequently pushing quality-of-life issues under the rug. This is the reality of pet healthcare in the U.S. — but we know we can do better. By using telehealth solutions to connect pet parents with licensed veterinarians, Dutch makes veterinary visits convenient and practical. Dutch-affiliated vets work with your pet over time, whenever they need it, allowing our veterinarians to go beyond the symptoms and identify the root cause of your pet’s chronic suffering. We prescribe treatments and prescriptions that are medically backed, specialized to individual cases, and delivered directly to your door. Dutch currently operates in the following eight states: New York, Pennsylvania, New Jersey, Michigan, South Dakota, Virginia, Idaho, and Indiana.

Dutch has raised $38.0M across 2 rounds on record. The most recent is a Series B of $18.0M announced in Oct 2023.

Dutch's most recent funding round on record is a Series B of $18.0M, announced in Oct 2023.

Joe Spector is listed as CEO at Dutch.

Dutch is based in Oakland, California, United States.

Dutch is in the 11-50 employee band.

Dutch's latest round of $18.0M is above the $2.3M median round size for Community and Lifestyle companies on FundedIQ across 1,484 tracked companies over the last two years.